AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Davenport, M. S.
Right arrow Articles by Fox, G. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davenport, M. S.
Right arrow Articles by Fox, G. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.08.1303
AJR 2009; 192:1571-1578
© American Roentgen Ray Society


Original Research

MRI and CT Characteristics of Successfully Ablated Renal Masses: Imaging Surveillance After Radiofrequency Ablation

Matthew S. Davenport1, Elaine M. Caoili, Richard H. Cohan, James H. Ellis, Ellen J. Higgins, Jonathon Willatt and Giovanna A. Fox

1 All authors: Department of Radiology, University of Michigan Medical Center and University of Michigan Health Systems, 1500 E Medical Center Dr., SPC 5030, UH B1 D530C, Ann Arbor, MI 48109-5030.

OBJECTIVE. The objective of our study was to evaluate the evolution of the appearances of successfully ablated renal masses on CT and MRI.

MATERIALS AND METHODS. We conducted a retrospective review of 28 solid renal masses in 25 patients who underwent percutaneous radiofrequency ablation (RFA) between July 2003 and July 2006 in whom there was no evidence of residual tumor during at least 1 year of imaging follow-up and there was postablation biopsy proof of nonviable tissue within the ablation cavity. Three radiologists assessed the size, morphology, and CT or MRI characteristics of the initial tumor and of the ablated tumor or ablation cavity at imaging follow-up 1–2, 3–5, 6–11, and 12–24 months after RFA.

RESULTS. The mean initial tumor volume was 5.5 cm3 (range, 0.3–22.3 cm3). Within 1–2 months, the postablation beds of small masses (≤ 3 cm3) were larger than the volume of the initial tumor. Large masses (> 3 cm3) did not show this increase in volume. At 12 months after RFA, the postablation beds had decreased in size but had not disappeared. On CT, the postablation beds did not show enhancement at any time. On MRI, the postablation beds often showed a thin rim of peripheral enhancement. Imaging follow-up often revealed local stranding in the perinephric fat adjacent to the ablation site. Exophytic tumors were more likely to separate from the renal parenchyma as they contracted toward their epicenter and were more likely to reveal a complete halo of soft-tissue attenuation in the adjacent perinephric fat, which became more apparent on the longer-term follow-up imaging studies.

CONCLUSION. Successfully ablated tumors show predictable imaging features that can be used to guide interpretation of CT and MRI surveillance examinations.

Keywords: kidney disease • MRI • oncologic imaging • radiofrequency ablation • renal cell carcinoma • renal masses


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Roentgen Ray Society.